Orchid Pharma Ltd
NSE:ORCHPHARMA

Watchlist Manager
Orchid Pharma Ltd Logo
Orchid Pharma Ltd
NSE:ORCHPHARMA
Watchlist
Price: 808.55 INR -4.14% Market Closed
Market Cap: 41B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+18%
Operating Income
Forecast
+22%
Net Income
Forecast
+22%

Wall Street
Price Targets

ORCHPHARMA Price Targets Summary
Orchid Pharma Ltd

Wall Street analysts forecast ORCHPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 532.72 INR with a low forecast of 1 105.95 INR and a high forecast of 1 935.15 INR.

ORCHPHARMA Lowest Forecast
Wall Street Target
1 105.95 INR
37% Upside
ORCHPHARMA Average Forecast
Wall Street Target
1 532.72 INR
90% Upside
ORCHPHARMA Highest Forecast
Wall Street Target
1 935.15 INR
139% Upside
Lowest
Price Target
1 105.95 INR
37% Upside
Average
Price Target
1 532.72 INR
90% Upside
Highest
Price Target
1 935.15 INR
139% Upside
Orchid Pharma Ltd Competitors:
Price Targets
ALKEM
Alkem Laboratories Ltd
9% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
52% Upside
000423
Dong-E-E-Jiao Co Ltd
28% Upside
VETO
Vetoquinol SA
31% Upside
ALKEM
Alkem Laboratories Ltd
9% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
52% Upside
000423
Dong-E-E-Jiao Co Ltd
28% Upside
VETO
Vetoquinol SA
31% Upside
2161
Jbm (Healthcare) Ltd
9% Upside
ITCI
Intra-Cellular Therapies Inc
1% Upside
SNDL
Sundial Growers Inc
140% Upside

Revenue
Forecast

Revenue Estimate
Orchid Pharma Ltd

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

-1%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Orchid Pharma Ltd

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's operating income is 15%. The projected CAGR for the next 3 years is 64%.

15%
Past Growth
64%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Orchid Pharma Ltd

The compound annual growth rate of Orchid Pharma Ltd's net income for the next 3 years is 44%.

N/A
Past Growth
44%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ORCHPHARMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORCHPHARMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORCHPHARMA stock valuation using valuation multiples.
Wall Street Estimates
ORCHPHARMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORCHPHARMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORCHPHARMA's stock price target?
Price Target
1 532.72 INR

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 532.72 INR with a low forecast of 1 105.95 INR and a high forecast of 1 935.15 INR.

What is Orchid Pharma Ltd's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's revenue is -1%. The projected CAGR for the next 3 years is 33%.

What is Orchid Pharma Ltd's Operating Income forecast?
Projected CAGR
64%

For the last 8 years the compound annual growth rate for Orchid Pharma Ltd's operating income is 15%. The projected CAGR for the next 3 years is 64%.

What is Orchid Pharma Ltd's Net Income forecast?
Projected CAGR
44%

The compound annual growth rate of Orchid Pharma Ltd's net income for the next 3 years is 44%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.